About Biospot
Biospot was a Healthcare company based in Coimbatore (India) founded in 2016. Biospot provides tools for discovering biomarkers in human blood and tissue samples. It operates on a B2B model. The company is recorded as dissolved. Its focus areas include Biotechnology, Biomarkers and Sample Analysis Tools. Its legal entity in India is Biospot Solutions Private Limited (U72100TZ2016PTC027752). Similar companies include Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group and 5 more; 8 of its 10 listed similar companies have raised funding.
Company details
Biospot, established in 2016 and currently in Dissolved stage, focuses on providing healthcare solutions, advancing biotech innovations, biomarkers, and sample analysis tools. Biospot provides tools for discovering biomarkers in human blood and tissue samples. Adapting to market demands with innovation and client-focused strategies.
- Headquarters Coimbatore, India
- SectorsHealthcare
- Website biospot.in
- Social X Facebook
- Legal Name Biospot Solutions Private Limited
- Date of Incorporation 08 Jul, 2016
- Jurisdiction Coimbatore, Tamil Nadu, India
- Annual Revenue₹17,500
FY 2025 · -30% YoY
- Net Loss-₹3,074
FY 2025 · -18% margin
- EBITDA₹12,240
FY 2025 · 70% margin
Associated legal entities of Biospot
Biospot operates through Biospot Solutions Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Biospot Solutions Private Limited CIN U72100TZ2016PTC027752 | Active | 08 Jul 2016 | Coimbatore, Tamil Nadu | ₹0.0 Cr | – | 2 | View details |
Board of directors of Biospot Solutions Private Limited (Biospot)
Biospot Solutions Private Limited is the primary company behind Biospot. The board of Biospot Solutions Private Limited currently have 2 directors; the longest-serving is Venkataraman Sowmya, appointed in 2016.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Venkataraman Sowmya DIN 07543941 | Director | 08 Jul 2016 | 10 yrs 3 mo | Biospot Solutions Private Limited |
| Rajendran Sathishkumar DIN 07513670 | Managing Director | 08 Jul 2016 | 10 yrs 3 mo | Biospot Solutions Private Limited |
Financials of Biospot
Figures of Biospot Solutions Private Limited, the primary company behind Biospot, for FY 2025. Revenue was ₹17,500 (-30% year on year). Net loss was -₹3,074 (-18% margin). EBITDA was ₹12,240 (70% margin). Revenue has grown at a compounded annual rate of -63% over three years and -45% over five years.
- ₹17,500Revenue · FY 2025 · -30% YoY
- -₹3,074Net loss · -18% margin
- ₹12,240EBITDA · 70% margin
- ₹1 LakhPaid-up capital
- -63%Revenue CAGR, 3 years
- -45%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Biospot Solutions Private Limited are on its company page.
Detailed financial statements for Biospot
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Biospot
Biospot has 10 listed similar companies in our database, 8 of them funded. They include Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| univercells.com | 2013 | Charleroi, Belgium | $150.64M | 87 | Biomanufacturing technologies are supplied for biopharma antibody and vaccine production. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform | |
| straumann.com | 1954 | Basel, Switzerland | – | – | Dental implants and regenerative dentistry products are developed. | |
| korrobio.com | 2018 | Cambridge, United States | $4M | 77 | RNA-editing technologies are provided for precision medicine applications. | |
| judges.uk.com | 2002 | London, United Kingdom | – | 622 | Acquisition and development of scientific instrument businesses is conducted. | |
| savarapharma.com | 2008 | Austin, United States | $67.82M | 37 | Therapeutics for rare respiratory diseases are developed by Savara Pharma. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. | |
| synthego.com | 2012 | Redwood, United States | $459.75M | – | CRISPR-engineered cell and gene therapies are developed for research applications. |
Detailed similar companies of Biospot
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as Biospot (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Biospot
Biospot was founded in 2016.
Biospot is headquartered in Coimbatore, India. It is registered at Coimbatore, Tamil Nadu, India.
The primary company behind Biospot, Biospot Solutions Private Limited, reported revenue of ₹17,500 for FY 2025, down 30% year on year.
Biospot, established in 2016 and currently in Dissolved stage, focuses on providing healthcare solutions, advancing biotech innovations, biomarkers, and sample analysis tools. Biospot provides tools for discovering biomarkers in human blood and tissue samples. Adapting to market demands with innovation and client-focused strategies.
Biospot's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Biospot operates through Biospot Solutions Private Limited.
The legal entities of Biospot currently have 2 directors, including Venkataraman Sowmya, Rajendran Sathishkumar.